Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. May 6, 2016; 7(2): 261-267
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.261
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.261
Variable | β | SE | Wald | P value | OR | 95%CI |
Age (≥ 56 yr) | 0.688 | 0.21 | 10.734 | 0.001 | 1.99 | 1.319-3.004 |
BMI (≥ 25 kg/m2) | 1.459 | 0.204 | 51.055 | < 0.001 | 4.301 | 2.883-6.417 |
BP (≥ 149/90 mmHg | 0.418 | 0.247 | 2.859 | 0.091 | 1.518 | 0.936-2.464 |
Hb (≥ 15.1 g/dL) | 0.293 | 0.203 | 2.098 | 0.148 | 1.341 | 0.902-1.995 |
Plt (≥ 20.9 × 104/μL) | -0.324 | 0.236 | 1.874 | 0.171 | 0.724 | 0.455-1.15 |
TC (≥ 219 mg/dL) | -0.104 | 0.316 | 0.108 | 0.743 | 0.901 | 0.485-1.674 |
TG (≥ 149 mg/dL) | 0.602 | 0.273 | 4.862 | 0.027 | 1.826 | 1.069-3.117 |
HDL-C (≥ 40 mg/dL) | 0.218 | 0.341 | 0.408 | 0.523 | 1.243 | 0.637-2.427 |
LDL-C (≥ 139 mg/dL) | 0.037 | 0.322 | 0.013 | 0.908 | 1.038 | 0.552-1.952 |
AST (≥ 30 IU/L) | -0.161 | 0.343 | 0.22 | 0.639 | 0.851 | 0.434-1.669 |
ALT (≥ 30 IU/L) | 0.022 | 0.302 | 0.005 | 0.942 | 1.022 | 0.566-1.847 |
GGT (≥ 51 IU/L) | -0.003 | 0.309 | 0 | 0.992 | 0.997 | 0.544-1.828 |
ALP (≥ 325 IU/L) | 0.124 | 0.37 | 0.113 | 0.737 | 1.132 | 0.548-2.34 |
ChE (≥ 350 IU/L) | -0.049 | 0.217 | 0.052 | 0.819 | 0.952 | 0.622-1.455 |
UA (≥ 5.8 mg/dL) | -0.085 | 0.232 | 0.133 | 0.716 | 0.919 | 0.583-1.448 |
FPG (≥ 110 g/dL) | -0.485 | 0.327 | 2.201 | 0.138 | 0.615 | 0.324-1.169 |
HbA1c (≥ 6.2%) | -0.162 | 0.532 | 0.093 | 0.761 | 0.85 | 0.3-2.414 |
Current drinking | 0.345 | 0.222 | 2.421 | 0.12 | 1.412 | 0.914-2.18 |
- Citation: Arakaki S, Maeshiro T, Hokama A, Hoshino K, Maruwaka S, Higashiarakawa M, Parrott G, Hirata T, Kinjo K, Fujita J. Factors associated with visceral fat accumulation in the general population in Okinawa, Japan. World J Gastrointest Pharmacol Ther 2016; 7(2): 261-267
- URL: https://www.wjgnet.com/2150-5349/full/v7/i2/261.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i2.261